ARCHIVES

Nancy Brinker Resigns As CEO of Komen

This article is from The Cancer Letter archive.

Vol. 38 No. 32 | August 10, 2012

Download PDF Visit The Full Archive

Related Articles

Clearinghouse Group Selects 10 More Compounds To Test

January 13, 1978

NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction

April 28, 2006

OMB Orders NCI to Cut 12 Percent Until Final budget Is Approved; Grants Being Renegotiated

December 4, 1981

Gene Therapy Alters Immune Cells For Treatment Of Advanced Melanoma

September 29, 2006

Public Forum On NRSA Tuition Policies

April 14, 1995

International Cancer Program Enthusiasm A Spinoff From U.S. Program, XIIth Congress Demonstrates

October 20, 1978